These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19345586)

  • 1. NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.
    Berger ML; Schweifer A; Rebernik P; Hammerschmidt F
    Bioorg Med Chem; 2009 May; 17(9):3456-62. PubMed ID: 19345586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
    Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
    J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-801 analogues: molecular properties required for recognition by the N-methyl-D-aspartate receptor.
    Leeson PD; James K; Carling RW; Wong EH; Baker R
    Prog Clin Biol Res; 1990; 361():513-8. PubMed ID: 2149766
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists.
    Banerjee A; Schepmann D; Köhler J; Würthwein EU; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):7855-67. PubMed ID: 20965735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study.
    Bergeron RJ; Weimar WR; Wu Q; Feng Y; McManis JS
    J Med Chem; 1996 Dec; 39(26):5257-66. PubMed ID: 8978854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of membrane phospholipids in inhibition by ferrous ions of [3H]MK-801 binding to the native N-methyl-D-aspartate channel in rat brain.
    Yoneda Y; Ogita K; Shuto M; Manabe T; Kitayama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Feb; 19(1):33-40. PubMed ID: 10374242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.
    Berger ML; Maciejewska D; Vanden Eynde JJ; Mottamal M; Żabiński J; Kaźmierczak P; Rezler M; Jarak I; Piantanida I; Karminski-Zamola G; Mayence A; Rebernik P; Kumar A; Ismail MA; Boykin DW; Huang TL
    Bioorg Med Chem; 2015 Aug; 23(15):4489-4500. PubMed ID: 26117647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol.
    Aepkers M; Wünsch B
    Bioorg Med Chem; 2005 Dec; 13(24):6836-49. PubMed ID: 16169732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
    Gilling KE; Jatzke C; Hechenberger M; Parsons CG
    Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
    Berger ML; Rebernik P
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4131-5. PubMed ID: 26296478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective synthesis and preliminary evaluation of new D-3-heteroarylcarbonylalanines as ligands of the NMDA receptor.
    Lima PG; Caruso RR; Alves SO; Pessôa RF; Mendonça-Silva DL; Nunes RJ; Noël F; Castro NG; Costa PR
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4399-403. PubMed ID: 15357961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New polyamine-sensitive inhibitors of the NMDA receptor: syntheses and pharmacological evaluation.
    Pöhler T; Schadt O; Niepel D; Rebernik P; Berger ML; Noe CR
    Eur J Med Chem; 2007 Feb; 42(2):175-97. PubMed ID: 17112642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the NMDA-receptor blocker MK-801 on sensitivity of the respiratory system to carbon dioxide].
    Tarakanov IA; Dymetska A; Tarasova NN
    Patol Fiziol Eksp Ter; 2005; (2):13-5. PubMed ID: 16078649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of gacyclidine enantiomers with 'non-NMDA' binding sites in the rat central nervous system.
    Hirbec H; Kamenka JM; Privat A; Vignon J
    Brain Res; 2001 Mar; 894(2):189-92. PubMed ID: 11251192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents.
    Berger ML; Bitar AY; Waitner MJ; Rebernik P; O'Sullivan MC
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2837-41. PubMed ID: 16563762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of noncompetitive antagonists of the NMDA receptor: proposal of a pharmacophore and a description of the interaction mode.
    Elhallaoui M; Laguerre M; Carpy A; Ouazzani FC
    J Mol Model; 2002 Feb; 8(2):65-72. PubMed ID: 12032600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the polyamine regulatory site of the NMDA receptor: a parallel synthesis approach.
    Berger ML; Pöhler T; Schadt O; Stanger M; Rebernik P; Scholze P; Noe CR
    ChemMedChem; 2013 Jan; 8(1):82-94. PubMed ID: 23225329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: differences with receptors formed from NR 1a and 2A.
    Lynch DR; Lawrence JJ; Lenz S; Anegawa NJ; Dichter M; Pritchett DB
    J Neurochem; 1995 Apr; 64(4):1462-8. PubMed ID: 7891073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential.
    Porter RH; Greenamyre JT
    J Neurochem; 1995 Feb; 64(2):614-23. PubMed ID: 7530291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.